Sɔmbɔdi na yu famili, sɔntɛm yu mama, papa, ɔ yu layf patna we yu lɛk, gɛt wan sik we dɛn kɔl Alzaima? Dɔn yu go dɔn no gud gud wan aw i nɔ kin izi fɔ ɔlman na di famili ɛn i kin mek i fil pen. E nɔr kin izi fɔ wach dis sik wae yu nɔr de mɛmba ɛvride ɛn fɔgɛt udat yu bi. So we nyus kam bɔt nyu mɛrɛsin fɔ dis sik, i kin briŋ big op ɛn bɔku kwɛstyɔn dɛn na wi maynd. "Dis rili wok? Eni sayd effekt de? Udat fit yuz dis?" Bɔku kwɛstyɔn dɛn go mɔs de na yu maynd. So lɛ wi tɔk bɔt ɔltin klia wan ɛn simpul wan tide.
Wetin na dis nyu mɛrɛsin we de tɔk?
Di nem fɔ dis nyu mɛrɛsin na Lecanemab, ɛn dɛn go sɛl am ɔnda di nem Leqembi. Fɔs, di impɔtant tin we wi ɔl fɔ ɔndastand na dat dis nɔto mɛrɛsin fɔ Alzaima sik. Bɔt, i de du big tin. Dat min se, i de slo di sik fɔ go bifo we i bigin . Fɔ tɔk am simpul wan, i kin mek di pɔsin we sik nɔ ebul fɔ mɛmba ɛn tink gud wan.
Dɛn kin gi dis as infushɔn we dɛn kin put insay di bɛlɛ ɛvri tu wik. Dɛn kin put di mɛrɛsin smɔl smɔl insay di bɔdi, jɔs lɛk salin.
Aw dis mɛrɛsin de wok?
Imajin, we wi gɛt Alzaima sik, sɔntin we stika ɛn lɛk dɔti kin gɛda bitwin wi bren sɛl dɛn. Wi kin kɔl dis amyloid. dis protin we dεn kכl amyloid na di men tin we de mek di bren sεl dεm pwεl εn di mεmכri lכs. So wetin dis nyu dכg de du na fכ tכk to dis amyloid protin we dεn nכ want na di bren εn pul am. In ɔda wɔd, dis drɔg de atak di rut fɔ di sik.
Dis na big step fɔ go bifo pan wi mɛdikal fild. Bikɔs bɔku pan di mɛrɛsin dɛn we dɔn de fɔ lɔng tɛm dɔn jɔs ebul fɔ kɔntrol sɔm pan di sayn dɛn we de sho se pɔsin gɛt dis sik. Bɔt dis mɛrɛsin de tray fɔ chenj aw di sik de go.
Wetin na di bad tin dɛn we kin apin ɛn di prɔblɛm dɛn we kin apin we dis kin apin?
Lɛk ɛni mɛrɛsin, dis wan gɛt in gud ɛn bad tin dɛn. I impɔtant fɔ mek wi no ɔl tu.
Risach dɔn sho se di pasɛnt dɛn we tek dis mɛrɛsin fɔ 18 mɔnt bin gɛt 27% ridɔkshɔn pan mɛmori ɛn tink abiliti we yu kɔmpia am wit di plasɛbo grup. di amount of amyloid na di bren bin ridyus bak bad bad wan. Pan ɔl we dis kin tan lɛk smɔl pasɛnt, na big tin fɔ mek pɔsin we sik kin stil si di wan dɛn we i lɛk ɛn du in wok fɔ sɔm mɔnt mɔ.
Bɔt, wi no bak bɔt di prɔblɛm dɛn we kin apin.
di men risk fכ dis dכg na wan kכndyushכn we dεn kכl ARIA (amyloid-related imaging abnormalities). Fɔ tɔk am simpul wan, dis kin mek smɔl smɔl swel ɔ smɔl blɔd kɔmɔt na di bren.I kin apin. Insay risach, dɛn dɔn ripɔt dis kɔndishɔn pan lɛk 14% pan di pipul dɛm wae tek di drɔg. Bɔt fɔ bɔku pipul dɛn, dis nɔ kin mek dɛn gɛt big big sik. Bɔt, i nɔ kin rili siriɔs.
Dis risk kin bɔku mɔ fɔ di wan dɛn we de tek mɛrɛsin we de mek dɛn blɔd tan . So, i impɔtant fɔ mek di pɔsin tɛl di dɔktɔ bɔt ɔl di ɔda mɛrɛsin dɛn we i de tek bifo i bigin dis mɛrɛsin.
Apat frɔm dat, sayd ɛfɛkt dɛn lɛk fiva, bɔdi we de at, nɔs, vɔmit, ɛn chenj na di blɔd prɛshɔn kin apin we dɛn de gi di injɛkshɔn.
| Di gud tin dɛn we pɔsin kin du | Risk ɛn Kɔns |
|---|---|
| I de slo fɔ mek yu nɔ mɛmba fayn we di sik bigin. | Risk fɔ mek yu bren swel ɛn blɔd (ARIA). |
| I de pul di bad bad amyloid protin dεm na di bren. | Dɛn fɔ injekt am na wan vein ɛvri tu wik. |
| Bring nyu op fɔ trit di sik. | Bikɔs i rili dia intanashɔnal wan. |
| Gi mɔ tɛm to di pɔsin ɛn in famili. | Sayd ɛfɛkt lɛk fiva ɛn nɔs kin apin. |
Udat rili dis mɛrɛsin fayn fɔ?
Dis na di pɔynt we impɔtant pas ɔl. Dis mɛrɛsin nɔr fayn fɔ ɔlman wae gɛt Alzaima.
- Na fɔ di wan dɛn nɔmɔ we dɔn bigin fɔ gɛt di sik: Dis mɛrɛsin kin wok fayn fɔ di wan dɛn we de na di fɔs stej fɔ di sik, we min se dɛn jɔs bigin fɔ sho di sayn dɛm. I nɔ kin wok fayn fɔ di wan dɛn we de na di let stej fɔ di sik, we di sik kin tranga pasmak.
- amyloid fכ kכnfכm: I nid fכ kכnfכm se di sikman gεt amyloid dεposit dεm na in bren tru spεshal tεst dεm (PET skan כ lכmba pankshכn).
- Nɔr fɔ ɔda kayn dis maynia sik: Dis mɛrɛsin nɔr fayn fɔ ɔda kayn mɛmori, ɔda pas Alzaima (e.g. vaskul dimɛnshɔn).
So, na wan dɔktɔ we de mɛn di nyurolɔjis nɔmɔ go disayd if dis mɛrɛsin fayn fɔ pɔsin we sik.
Prays ɛn kɔndishɔn na Sri Lanka
Di prayz fɔ dis mɛrɛsin rili ay. Di mɔni we dɛn kin spɛn ɛvri ia na Amɛrika na lɛk 26,500 dɔla (i pas 8 milyɔn Sri Lanka mɔni). I kin tek sɔm tɛm fɔ mek dɛn rɛjista dis kayn nyu, spɛshal ɛn dia mɛrɛsin na wi kɔntri ɛn kam fɔ ɔdinari pasɛnt dɛn. Dɔn bak, bikɔs di prayz bɔku, i kin rili at fɔ mek ɔlman gɛt am.
Bɔt, dis na big op fɔ tumara bambay. We sayɛns dɔn go bifo, wi op se wan de, dɛn go mek dɛn kayn mɛrɛsin ya mɔ ɛn mɔ ɛn ɔlman go ebul fɔ bay dɛn ɛn i go izi fɔ gɛt dɛn.
Mɛsej we dɛn kin kɛr go na os
- Lecanemab nɔto mɛrɛsin fɔ Alzaima sik, bɔt na mɛrɛsin we de mek di sik nɔ go bifo kwik kwik wan .
- dis de pul di bad bad amyloid protin dεm na di bren, bכt i gεt denja sayd ifekt dεm lεk di bren swel εn blɔd.
- Dis mɛrɛsin nɔ fayn fɔ ɔlman, mɔ fɔ di wan dɛn we de na di fɔs stej fɔ di sik ɛn dɛn dɔn kɔnfyus se dɛn gɛt amyloid na dɛn bren.
- Dis na tin we rili dia, ɛn dɛn nɔ shɔ bɔt aw i go de na Sri Lanka naw.
- If pɔsin na yu famili gɛt Alzaima sik, go to yu dɔktɔ fɔ tɔk bɔt ɛni nyu tritmɛnt ɔr mɛrɛsin. Nɔ disayd bay wetin yu de si na di Intanɛt.











💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt